prikaz prve stranice dokumenta Nuspojave antipsihotika tijekom liječenja shizofrenije
  Download
PDF 702.33 KB
master's thesis
Nuspojave antipsihotika tijekom liječenja shizofrenije
2017. urn:nbn:hr:152:681132
Šušak, Katarina
Josip Juraj Strossmayer University of Osijek
Faculty of Medicine Osijek

Cite this document

Šušak, K. (2017). Nuspojave antipsihotika tijekom liječenja shizofrenije (Master's thesis). Osijek: Josip Juraj Strossmayer University of Osijek, Faculty of Medicine Osijek. Retrieved from https://urn.nsk.hr/urn:nbn:hr:152:681132

Šušak, Katarina. "Nuspojave antipsihotika tijekom liječenja shizofrenije." Master's thesis, Josip Juraj Strossmayer University of Osijek, Faculty of Medicine Osijek, 2017. https://urn.nsk.hr/urn:nbn:hr:152:681132

Šušak, Katarina. "Nuspojave antipsihotika tijekom liječenja shizofrenije." Master's thesis, Josip Juraj Strossmayer University of Osijek, Faculty of Medicine Osijek, 2017. https://urn.nsk.hr/urn:nbn:hr:152:681132

Šušak, K. (2017). 'Nuspojave antipsihotika tijekom liječenja shizofrenije', Master's thesis, Josip Juraj Strossmayer University of Osijek, Faculty of Medicine Osijek, accessed 02 April 2025, https://urn.nsk.hr/urn:nbn:hr:152:681132

Šušak K. Nuspojave antipsihotika tijekom liječenja shizofrenije [Master's thesis]. Osijek: Josip Juraj Strossmayer University of Osijek, Faculty of Medicine Osijek; 2017 [cited 2025 April 02] Available at: https://urn.nsk.hr/urn:nbn:hr:152:681132

K. Šušak, "Nuspojave antipsihotika tijekom liječenja shizofrenije", Master's thesis, Josip Juraj Strossmayer University of Osijek, Faculty of Medicine Osijek, Osijek, 2017. Available at: https://urn.nsk.hr/urn:nbn:hr:152:681132

Please login to the repository to save this object to your list.
Metadata
TitleNuspojave antipsihotika tijekom liječenja shizofrenije
Title (english)Side effects of antypsychotics
AuthorKatarina Šušak
MentorLjiljana Radanović Grgurić (mentor)
Committee memberIvan Požgain (predsjednik povjerenstva)
Committee memberDunja Degmečić (član povjerenstva)
Committee memberLjiljana Radanović Grgurić (član povjerenstva)
GranterJosip Juraj Strossmayer University of Osijek
Faculty of Medicine Osijek
Osijek
Defense date and country2017-06-29, Croatia
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Abstract
Cilj istraživanja: Temeljni je cilj istraživanja utvrditi pojavnost nuspojava prilikom primjene antipsihotika kod bolesnika sa shizofrenijom hospitaliziranih na Klinici za psihijatriju KBC-a Osijek tijekom 2016. godine, kategorizirati nuspojave prema vrsti (motoričke i metaboličke nuspojave) i prema antipsihotiku (tipični i atipični) te procijeniti utjecaj nuspojave na tijek i ishod liječenja. Ustroj studije: Presječna studija Ispitanici i metode: U istraživanje je uključeno 120 bolesnika s... More dijagnozom shizofrenije prema MKB-10 kriterijima, hospitaliziranih na Klinici za psihijatriju KBC-a Osijek tijekom 2016. godine. Iz medicinske dokumentacije bolesnika prikupljeni su podatci o dobi i spolu, dijagnozi, vrsti i dužini primjene antipsihotika. Utvrđena je prisutnost metaboličkih i motoričkih nuspojava te poduzete mjere za redukciju nuspojava. Osim toga, procijenjen je utjecaj nuspojave na tijek i ishod liječenja tj. odgovor bolesnika nakon promjene terapije. Rezultati: Od 120 bolesnika, nuspojave su se javile kod 82 (68,3 %) bolesnika. Među metaboličkim nuspojavama najčešća je povišena razina kolesterola, kod 53 (65 %) bolesnika, a najčešća motorička nuspojava je parkinsonizam, prisutan kod 8 (10 %) bolesnika. Najčešće su primjenjivani lijekovi atipični antipsihotici risperidon, klozapin, paliperidon, a među tipičnim najzastupljeniji su promazin, flufenazin, haloperidol. Bolesnici s akutnim psihotičnim poremećajem nalik na shizofreniju češće su liječeni tipičnim antipsihotikom. Zaključak: Nuspojave su relativno česte tijekom primjene antipsihotika, što je prilično važno zbog utjecaja nuspojava na tijek, ali i ishod liječenja. Odgovarajući antipsihotik treba izabrati individualno za svakog bolesnika, tako da se u obzir uzmu i njegovi potencijalni rizici za razvoj pojedinih nuspojava. Less
Abstract (english)
Objective: The main objective of the study was to determine the side effects in using antipsychotics in patients with schizophrenia, hospitalized at the Clinical Hospital Center Osijek, at Psychiatric Clinic in 2016, as well as categorizing side effects by type (motor and metabolic side effects) and antipsychotics (typical and atypical). Furthermore, the aim was to evaluate the influence of side effects on the course and the outcome of the treatment. Study design: Cross-sectional study... More Participants and methods: The study included 120 patients with schizophrenia according to MKB-10 criteria, hospitalized at Clinical Hospital Center Osijek, at Psychiatric Clinic in 2016. Data on age, sex, diagnosis, the type and the length of the use of antipsychotics were taken from patients’ medical records. Metabolic and motor side effects were recorded and certain actions were performed in order to reduce them. In addition, we estimated the impact of side effects on the course and the outcome of the treatment, i.e. patients’ response to the applied therapy. Results: Out of 120 patients, 82 (68.3%) reported side effects. Among metabolic side effects, the most common was elevated cholesterol level, found in 53 (65%) patients, and the most common motor side effect was parkinsonism, present in 8 (10%) patients. The most commonly used atypical antipsychotics were risperidone, clozapine, paliperidone, and among the most commonly used typical antipsychotics were promazine, flufenazine and haloperidol. Patients with schizophrenic acute psychotic disorder are more often treated with typical antipsychotics. Conclusion: Side effects are relatively common in the use of antipsychotics, which is quite important to take into consideration due to the influence of side effects on the course, but also the outcome of the treatment. Appropriate antipsychotics should be selected individually for each patient, so we have to take into account their potential risks of the development of certain side effects. Less
Keywords
Keywords (english)
Languagecroatian
URN:NBNurn:nbn:hr:152:681132
Study programmeTitle: University Graduate Studies
Study programme type: university
Study level: integrated undergraduate and graduate
Academic / professional title: doktor/doktorica medicine (doktor/doktorica medicine)
Type of resourceText
File originBorn digital
Access conditionsOpen access
Terms of useLicence In copyright icon
Created on2017-07-27 12:05:22
accessibility

closeAccessibilityrefresh

If you wish to permanently save changes, click on Save, if not - your settings will be reset when you restart the browser.